.png)
Agenzia Italiana del Farmaco
home
Highlights
-
27 Mar 2026
Monitoring pharmaceutical expenditure
Biosimilars: AIFA webinar on the Third Position Paper
It will be held remotely on April 9th from 10:30 am to 1:30 pm to outline the contents of the new version and encourage direct discussion with stakeholders.
-
26 Mar 2026
Press releases
The Board of Directors has given the go-ahead for reimbursing a new medicine, seven extensions of therapeutic indications and three generic equivalents
The medicines to be reimbursed include new indications for the treatment of metastatic prostate cancer, newly diagnosed multiple myeloma and hepatitis delta virus (HDV) infection, as well as a medicine for pre-exposure prophylaxis against HIV-1 infection.
-
24 Mar 2026
Press releases
AIFA and FIASO: a strategic alliance for patient safety, appropriate care and the sustainability of the NHS
Building a stable framework aimed at improving the quality of care, safeguarding patient safety and ensuring the long-term sustainability of the National Health Service: this is the shared commitment reaffirmed by the leaders of AIFA and FIASO (Italian Federation of Local Health and Hospital Authorities) during the meeting held at the Agency’s headquarters.
-
24 Mar 2026
Press releases
Drug negotiations: new ‘simplified’ and ‘fast-track’ procedures launched
The aim is to shorten the time taken for procedures relating to the inclusion of medicines on the reimbursement lists, whilst ensuring financial sustainability for the National Health Service.
News
26 Mar 2026
Information and communication
How to protect yourself from fake ‘miracle cures’: AIFA recommendations
27 Mar 2026
Safety of medicinal products
Levamisole: the PRAC recommendation for withdrawal from the EU market has been confirmed
20 Mar 2026
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Remsima (infliximab)
18 Mar 2026
Press releases
AIFA clarification on the opinion regarding reimbursement of Alzheimer's medicines
16 Mar 2026
Transparency Lists
AIFA updates the Transparency Lists
16 Mar 2026
Press releases
AIFA strengthens its commitment to inclusion
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
